Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-07 Sale | 2024-03-11 8:33 pm | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO | 61,277 | $66.07 | $4,048,400 | 1,070,875 (Direct) | View |
| 2024-03-07 Sale | 2024-03-11 8:33 pm | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance, CFO | 23,253 | $66.32 | $1,542,147 | 10,121 (Direct) | View |
| 2024-03-07 Sale | 2024-03-11 8:32 pm | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 20,477 | $66.09 | $1,353,235 | 7,345 (Direct) | View |
| 2024-03-07 Sale | 2024-03-11 8:31 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 20,477 | $66.23 | $1,356,110 | 37,045 (Direct) | View |
| 2024-03-07 Sale | 2024-03-11 8:31 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 10,162 | $66.21 | $672,791 | 27,148 (Direct) | View |
| 2024-02-27 Sale | 2024-02-28 7:41 pm | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 20,000 | $72.93 | $1,458,650 | 9,611 (Direct) | View |
| 2024-02-26 Sale | 2024-02-27 8:00 pm | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 7,907 | $69.53 | $549,784 | 0 (Direct) | View |
| 2024-02-26 Sale | 2024-02-27 8:00 pm | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance, CFO | 13,337 | $69.43 | $925,961 | 0 (Direct) | View |
| 2024-02-26 Sale | 2024-02-27 7:59 pm | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO | 22,590 | $69.79 | $1,576,464 | 1,050,309 (Direct) | View |
| 2024-02-26 Sale | 2024-02-27 7:58 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 4,112 | $70.17 | $288,534 | 9,488 (Direct) | View |
| 2024-02-26 Sale | 2024-02-27 7:58 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 7,907 | $70.13 | $554,491 | 29,700 (Direct) | View |
| 2024-02-26 Sale | 2024-02-27 7:57 pm | Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director | 26,328 | $68.68 | $1,808,253 | 49,662 (Indirect Direct) | View |
| 2024-02-02 Sale | 2024-02-05 6:13 pm | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 11,860 | $66.42 | $787,719 | 0 (Direct) | View |
| 2024-02-02 Sale | 2024-02-05 6:10 pm | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO | 33,885 | $67.07 | $2,272,694 | 1,050,309 (Direct) | View |
| 2024-02-02 Sale | 2024-02-05 6:07 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 11,860 | $67.15 | $796,367 | 29,700 (Direct) | View |
| 2024-02-02 Sale | 2024-02-05 6:05 pm | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance, CFO | 11,183 | $66.62 | $745,037 | 0 (Direct) | View |
| 2024-02-02 Sale | 2024-02-05 6:02 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 6,167 | $67.19 | $414,355 | 5,693 (Direct) | View |
| 2024-01-16 Sale | 2024-01-18 7:47 pm | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO | 191,362 | $66.27 | $12,680,892 | 1,260,141 (Direct) | View |
| 2024-01-11 Sale | 2024-01-12 6:02 pm | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 50,000 | $66.83 | $3,341,699 | 22,869 (Direct) | View |
| 2024-01-02 Sale | 2024-01-04 7:54 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 62,282 | $70.6 | $4,397,113 | 0 (Direct) | View |
| 2023-12-13 Sale | 2023-12-15 5:01 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 21,262 | $65 | $1,382,030 | 0 (Direct) | View |
| 2023-11-13 Sale | 2023-11-14 5:33 pm | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 50,000 | $53.9 | $2,694,783 | 46,115 (Direct) | View |
| 2023-11-06 Sale | 2023-11-08 5:31 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 42,393 | $55.63 | $2,358,152 | 29,700 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-31 Option Award | 2024-04-02 4:15 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 79 | $69.2 | 9,690 (Direct) | View |
| 2024-03-31 Option Award | 2024-04-02 4:15 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 260 | $69.2 | 99,495 (Direct) | View |
| 2024-03-20 Exercise | 2024-03-22 4:12 pm | N/A 2024-03-21 | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 20,000 | $0 | 99,235 (Direct) | View |
| 2024-03-20 Exercise | 2024-03-22 4:12 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 20,000 | $18.56 | 99,235 (Direct) | View |
| 2024-03-10 Exercise | 2024-03-11 8:33 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO | 20,565 | $0 | 1,070,875 (Direct) | View |
| 2024-03-10 Exercise | 2024-03-11 8:33 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance, CFO | 10,121 | $0 | 10,121 (Direct) | View |
| 2024-03-10 Exercise | 2024-03-11 8:33 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance, CFO | 4,539 | $56.73 | 10,121 (Direct) | View |
| 2024-03-10 Exercise | 2024-03-11 8:32 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 7,345 | $0 | 7,345 (Direct) | View |
| 2024-03-10 Exercise | 2024-03-11 8:31 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 7,345 | $0 | 37,045 (Direct) | View |
| 2024-03-10 Exercise | 2024-03-11 8:31 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 7,345 | $0 | 27,148 (Direct) | View |
| 2024-03-06 Exercise | 2024-03-08 5:59 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 13,132 | $0 | 69,098 (Direct) | View |
| 2024-03-06 Exercise | 2024-03-08 5:59 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO | 40,712 | $0 | 1,172,446 (Direct) | View |
| 2024-03-06 Exercise | 2024-03-08 5:58 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 13,132 | $0 | 39,398 (Direct) | View |
| 2024-03-06 Exercise | 2024-03-08 5:58 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance, CFO | 13,132 | $0 | 39,398 (Direct) | View |
| 2024-03-06 Exercise | 2024-03-08 5:58 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 13,132 | $0 | 48,886 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 7:05 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 36,717 | $0 | 36,717 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 7:05 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance, CFO | 26,227 | $0 | 26,227 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 7:05 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 26,227 | $0 | 26,227 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 7:04 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 26,227 | $0 | 26,227 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 7:02 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO | 104,909 | $0 | 104,909 (Direct) | View |
| 2024-02-27 Exercise | 2024-02-28 7:41 pm | N/A 2024-03-21 | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 20,000 | $0 | 9,611 (Direct) | View |
| 2024-02-27 Exercise | 2024-02-28 7:41 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 20,000 | $18.56 | 9,611 (Direct) | View |
| 2024-02-23 Exercise | 2024-02-27 8:00 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 7,907 | $0 | 0 (Direct) | View |
| 2024-02-26 Exercise | 2024-02-27 8:00 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance, CFO | 5,882 | $36.89 | 0 (Direct) | View |
| 2024-02-23 Exercise | 2024-02-27 8:00 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance, CFO | 13,337 | $0 | 0 (Direct) | View |
| 2024-02-23 Exercise | 2024-02-27 7:59 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO | 22,590 | $0 | 1,050,309 (Direct) | View |
| 2024-02-23 Exercise | 2024-02-27 7:58 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 7,907 | $0 | 9,488 (Direct) | View |
| 2024-02-23 Exercise | 2024-02-27 7:58 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 7,907 | $0 | 29,700 (Direct) | View |
| 2024-02-26 Exercise | 2024-02-27 7:57 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director | 20,000 | $43.45 | 49,662 (Direct) | View |
| 2024-02-26 Exercise | 2024-02-27 7:57 pm | N/A 2031-06-20 | Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director | 36,757 | $0 | 49,662 (Direct) | View |
| 2024-02-26 Exercise | 2024-02-27 7:57 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director | 16,757 | $55.48 | 49,662 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 6:13 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 11,860 | $0 | 0 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 6:10 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO | 33,885 | $0 | 1,050,309 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 6:07 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 11,860 | $0 | 29,700 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 6:05 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance, CFO | 11,183 | $0 | 0 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 6:02 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 11,860 | $0 | 5,693 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-18 7:47 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO | 191,362 | $16.86 | 1,260,141 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-18 7:47 pm | N/A 2024-06-30 | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO | 191,362 | $0 | 1,260,141 (Direct) | View |
| 2024-01-11 Exercise | 2024-01-12 6:02 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 46,115 | $12.73 | 22,869 (Direct) | View |
| 2024-01-11 Exercise | 2024-01-12 6:02 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 3,885 | $23.94 | 22,869 (Direct) | View |
| 2024-01-11 Exercise | 2024-01-12 6:02 pm | N/A 2029-01-07 | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 50,000 | $0 | 22,869 (Direct) | View |
| 2024-01-02 Exercise | 2024-01-04 7:54 pm | N/A 2028-08-15 | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 62,282 | $0 | 0 (Direct) | View |
| 2024-01-02 Exercise | 2024-01-04 7:54 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 62,282 | $19.87 | 0 (Direct) | View |
| 2023-12-31 Option Award | 2024-01-03 6:46 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 251 | $71.62 | 79,235 (Direct) | View |
| 2023-12-31 Option Award | 2024-01-03 6:43 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 76 | $71.62 | 9,611 (Direct) | View |
| 2023-11-13 Exercise | 2023-11-14 5:33 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 15,164 | $15.47 | 46,115 (Direct) | View |
| 2023-11-13 Exercise | 2023-11-14 5:33 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 34,836 | $12.73 | 46,115 (Direct) | View |
| 2023-11-13 Exercise | 2023-11-14 5:33 pm | N/A 2028-01-03 | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 50,000 | $0 | 46,115 (Direct) | View |
| 2023-11-06 Exercise | 2023-11-08 5:31 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 26,754 | $23.94 | 29,700 (Direct) | View |
| 2023-11-06 Exercise | 2023-11-08 5:31 pm | N/A 2030-02-17 | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 26,754 | $0 | 29,700 (Direct) | View |
| 2023-09-30 Option Award | 2023-10-02 5:30 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 105 | $52.09 | 9,535 (Direct) | View |
| 2023-09-30 Option Award | 2023-10-02 5:29 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 345 | $52.09 | 78,984 (Direct) | View |